Laboratory Software Intern, GRAIL

GRAIL is on a mission to improve cancer detection and save lives. By bringing together experts in bioinformatics, clinical science and deep learning, the company is building models from tumour genome sequencing data to provide actionable insights into how multiple types of cancers could be detected early using blood tests.

The development of these blood tests is supported by population-scale clinical studies. GRAIL is building an atlas characterising the levels of 'cell-free nucleic acids' (a key indicator of cancers) in thousands of individuals with and without cancer to help validate their early-stage tests. These will be some of the largest cancer-related studies ever to date. The company has also developed Garelli - a new blood test that has the ability to detect more than 50 types of cancer through a single blood draw, now becoming available on health insurance plans such as Curative Insurance.